![]() The transoesophageal ultrasound produces an image of the heart and shows its functioning, the same as with a conventional transthoracic echocardiogram, but the sound waves are sent through a tube that is inserted in the mouth and throat until it reaches the oesophagus. In the opinion of Carolina Bonilla, a clinical innovation specialist at GE Healthcare, “The development of this probe is a matter of great satisfaction to me and our R&D team because of the opportunities it provides for those most vulnerable of heart patients, children, while culminating the innovation work that started seven years ago with a fantastic team of professionals headed by Dr Ferran Rosés.” In the opinion of Luis Ortega, Ultrasound General Manager for GE Healthcare Iberia, “Our commitment to creating a world in which healthcare has no limits means we have developed the most state-of-the-art technology in pioneering paediatric cardiology on the market, providing healthcare professionals with a 4D paediatric probe to improve diagnosis and take action as quickly as possible, even in newborns with heart disease.” Due to this thickness, adult 4D transoesophageal probes cannot be used in patients under 20 kilos, for whom a 2D probe has been used up to now, providing less information and image detail.” ![]() All this is in a minimal sized probe, which means it can be used even in newborns over 5 kilos in weight.” Dr Gemma Giral, a paediatric cardiologist at Vall d’Hebron, states that, “The new 9VT-D technology has been built in miniature, enclosing the latest 4D technology in a flexible probe with a diameter of 3.5 millimetres, compared to ones measuring over 10 millimetres used in adult patients. ![]() Vall d’Hebron Barcelona Hospital Campus and General Electric Healthcare, a leading multinational company in the field of heart imaging, have co-developed the first 4D transoesophageal probe in the world that can explore the heart of all paediatric patients, from babies weighing over 5 kilos to adolescents: the 9VT-D.According to Dr Ferran Rosés, clinical head of Paediatric Cardiology at Vall d’Hebron, the CSUR (Centros, Servicios y Unidades de Referencia del Sistema Nacional de Salud ) reference centre in Catalonia for the healthcare of paediatric patients with heart disorders and the only centre in Catalonia with a paediatric heart failure and heart transplantation programme, “The new 9VT-D transoesophageal probe has an extraordinary image quality, which offers an exact correlation between the heart image and the patient’s anatomy, thus helping ensure greater planning of the surgical interventions and catheterisations each child requires. Knowing the exact physiology of each patient is crucial to improving the diagnosis and surgical treatment of congenital heart disease. In Catalonia alone, each year 600 children are born with congenital heart disease, of whom around 25% will require surgery, most of them before they reach the age of one. Congenital heart diseses are the most common congenital malformations: 8 out of every 1,000 children born in the world suffer from them.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |